Table of Contents
International Scholarly Research Notices
Volume 2014, Article ID 964051, 11 pages
http://dx.doi.org/10.1155/2014/964051
Review Article

Self-Microemulsifying Drug Delivery Systems: An Attractive Strategy for Enhanced Therapeutic Profile

1Vaageswari College of Pharmacy, Karimnagar, Telangana 505001, India
2Manipal College of Pharmaceutical Sciences, Manipal, Karnataka 576104, India

Received 10 August 2014; Accepted 20 November 2014; Published 8 December 2014

Academic Editor: Faiyaz Shakeel

Copyright © 2014 Samatha Akula et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Dahan and A. Hoffman, “Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs,” Journal of Controlled Release, vol. 129, no. 1, pp. 1–10, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Chakraborty, D. Shukla, B. Mishra, and S. Singh, “Lipid—an emerging platform for oral delivery of drugs with poor bioavailability,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 73, no. 1, pp. 1–15, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. R. N. Gursoy and S. Benita, “Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs,” Biomedicine and Pharmacotherapy, vol. 58, no. 3, pp. 173–182, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. C. W. Pouton and W. N. Charman, “The potential of oily formulations for drug delivery to the gastrointestinal tract: preface,” Advanced Drug Delivery Reviews, vol. 25, no. 1, pp. 1–2, 1997. View at Publisher · View at Google Scholar · View at Scopus
  5. A. J. Humberstone and W. N. Charman, “Lipid-based vehicles for the oral delivery of poorly water soluble drugs,” Advanced Drug Delivery Reviews, vol. 25, no. 1, pp. 103–128, 1997. View at Publisher · View at Google Scholar · View at Scopus
  6. S. di Maio and R. L. Carrier, “Gastrointestinal contents in fasted state and post-lipid ingestion: in vivo measurements and in vitro models for studying oral drug delivery,” Journal of Controlled Release, vol. 151, no. 2, pp. 110–122, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. V. Jannin, J. Musakhanian, and D. Marchaud, “Approaches for the development of solid and semi-solid lipid-based formulations,” Advanced Drug Delivery Reviews, vol. 60, no. 6, pp. 734–746, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. J.-L. Tang, J. Sun, and Z.-G. He, “Self-emulsifying drug delivery systems: strategy for improving oral delivery of poorly soluble drugs,” Current Drug Therapy, vol. 2, no. 1, pp. 85–93, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Stegemann, F. Leveiller, D. Franchi, H. de Jong, and H. Lindén, “When poor solubility becomes an issue: from early stage to proof of concept,” European Journal of Pharmaceutical Sciences, vol. 31, no. 5, pp. 249–261, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. M. R. A. Alex, A. J. Chacko, S. Jose, and E. B. Souto, “Lopinavir loaded solid lipid nanoparticles (SLN) for intestinal lymphatic targeting,” European Journal of Pharmaceutical Sciences, vol. 42, no. 1-2, pp. 11–18, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. M. C. Gohel, R. K. Parikh, S. C. Modi, K. G. Vyas, and K. M. Sheth, “Novel drug delivery approaches to bypass P-glycoprotein efflux pump,” Pharmainfo.net, vol. 9, no. 1, 2011, http://www.pharmainfo.net/reviews/novel-drug-delivery-approaches-bypass-p-glycoprotein-efflux-pump. View at Google Scholar
  12. P. P. Constantinides, J.-P. Scalart, C. Lancaster et al., “Formulation and intestinal absorption enhancement evaluation of water-in-oil microemulsions incorporating medium-chain glycerides,” Pharmaceutical Research, vol. 11, no. 10, pp. 1385–1390, 1994. View at Publisher · View at Google Scholar · View at Scopus
  13. A. S. Narang, D. Delmarre, and D. Gao, “Stable drug encapsulation in micelles and microemulsions,” International Journal of Pharmaceutics, vol. 345, no. 1-2, pp. 9–25, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Bansal, N. Akhtar, M. Jaggi, R. K. Khar, and S. Talegaonkar, “Novel formulation approaches for optimising delivery of anticancer drugs based on P-glycoprotein modulation,” Drug Discovery Today, vol. 14, no. 21-22, pp. 1067–1074, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. V. S. N. M. Dwibhashyam and J. Vijayaralna, “The permeability glycoprotein (P-GP)—a threat to effective drug therapy?” Indian Drugs, vol. 43, no. 8, pp. 609–615, 2006. View at Google Scholar · View at Scopus
  16. W.-T. Ke, S.-Y. Lin, H.-O. Ho, and M.-T. Sheu, “Physical characterizations of microemulsion systems using tocopheryl polyethylene glycol 1000 succinate (TPGS) as a surfactant for the oral delivery of protein drugs,” Journal of Controlled Release, vol. 102, no. 2, pp. 489–507, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. A. O. Nornoo, H. Zheng, L. B. Lopes, B. Johnson-Restrepo, K. Kannan, and R. Reed, “Oral microemulsions of paclitaxel: in situ and pharmacokinetic studies,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 71, no. 2, pp. 310–317, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. H.-J. Kim, K. A. Yoon, M. Hahn, E.-S. Park, and S.-C. Chi, “Preparation and in vitro evaluation of self-microemulsifying drug delivery systems containing idebenone,” Drug Development and Industrial Pharmacy, vol. 26, no. 5, pp. 523–529, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. K. R. Jadhav, I. M. Shaikh, K. W. Ambade, and V. J. Kadam, “Applications of microemulsion based drug delivery system,” Current Drug Delivery, vol. 3, no. 3, pp. 267–273, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. F. Buyukozturk, J. C. Benneyan, and R. L. Carrier, “Impact of emulsion-based drug delivery systems on intestinal permeability and drug release kinetics,” Journal of Controlled Release, vol. 142, no. 1, pp. 22–30, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. L. Djekic and M. Primorac, “The influence of cosurfactants and oils on the formation of pharmaceutical microemulsions based on PEG-8 caprylic/capric glycerides,” International Journal of Pharmaceutics, vol. 352, no. 1-2, pp. 231–239, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Gershanik and S. Benita, “Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 50, no. 1, pp. 179–188, 2000. View at Publisher · View at Google Scholar · View at Scopus
  23. C. J. H. Porter, C. W. Pouton, J. F. Cuine, and W. N. Charman, “Enhancing intestinal drug solubilisation using lipid-based delivery systems,” Advanced Drug Delivery Reviews, vol. 60, no. 6, pp. 673–691, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. C. W. Pouton and C. J. H. Porter, “Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies,” Advanced Drug Delivery Reviews, vol. 60, no. 6, pp. 625–637, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. H. N. Prajapati, D. M. Dalrymple, and A. T. M. Serajuddin, “A comparative evaluation of mono-, di- and triglyceride of medium chain fatty acids by lipid/surfactant/water phase diagram, solubility determination and dispersion testing for application in pharmaceutical dosage form development,” Pharmaceutical Research, vol. 29, no. 1, pp. 285–305, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. R. Nankervis, S. S. Davis, N. H. Day, and P. N. Shaw, “Effect of lipid vehicle on the intestinal lymphatic transport of isotretinoin in the rat,” International Journal of Pharmaceutics, vol. 119, no. 2, pp. 173–181, 1995. View at Publisher · View at Google Scholar · View at Scopus
  27. J. A. Yáñez, S. W. J. Wang, I. W. Knemeyer, M. A. Wirth, and K. B. Alton, “Intestinal lymphatic transport for drug delivery,” Advanced Drug Delivery Reviews, vol. 63, no. 10-11, pp. 923–942, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Sun, X. Zhai, K. Xue et al., “Intestinal absorption and intestinal lymphatic transport of sirolimus from self-microemulsifying drug delivery systems assessed using the single-pass intestinal perfusion (SPIP) technique and a chylomicron flow blocking approach: linear correlation with oral bioavailabilities in rats,” European Journal of Pharmaceutical Sciences, vol. 43, no. 3, pp. 132–140, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. D. J. Hauss, “Oral lipid-based formulations,” Advanced Drug Delivery Reviews, vol. 59, no. 7, pp. 667–676, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. K. Kohli, S. Chopra, D. Dhar, S. Arora, and R. K. Khar, “Self-emulsifying drug delivery systems: an approach to enhance oral bioavailability,” Drug Discovery Today, vol. 15, no. 21-22, pp. 958–965, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. X. Sha, G. Yan, Y. Wu, J. Li, and X. Fang, “Effect of self-microemulsifying drug delivery systems containing Labrasol on tight junctions in Caco-2 cells,” European Journal of Pharmaceutical Sciences, vol. 24, no. 5, pp. 477–486, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. R. P. Bagwe, J. R. Kanicky, B. J. Palla, P. K. Patanjali, and D. O. Shah, “Improved drug delivery using microemulsions: rationale, recent progress, and new horizons,” Critical Reviews in Therapeutic Drug Carrier Systems, vol. 18, no. 1, pp. 77–140, 2001. View at Google Scholar · View at Scopus
  33. C. W. Pouton, “Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and “self-microemulsifying” drug delivery systems,” European Journal of Pharmaceutical Sciences, vol. 11, no. 2, pp. S93–S98, 2000. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. Li and D. J. McClements, “Inhibition of lipase-catalyzed hydrolysis of emulsified triglyceride oils by low-molecular weight surfactants under simulated gastrointestinal conditions,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 79, no. 2, pp. 423–431, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. P. P. Constantinides, “Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects,” Pharmaceutical Research, vol. 12, no. 11, pp. 1561–1572, 1995. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Müllertz, A. Ogbonna, S. Ren, and T. Rades, “New perspectives on lipid and surfactant based drug delivery systems for oral delivery of poorly soluble drugs,” Journal of Pharmacy and Pharmacology, vol. 62, no. 11, pp. 1622–1636, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. M. M. Bandivadeka, S. S. Pancholi, R. Kaul-Ghanekar, A. Choudhari, and S. Koppikar, “Self-microemulsifying smaller molecular volume oil (Capmul MCM) using non-ionic surfactants: a delivery system for poorly water-soluble drug,” Drug Development and Industrial Pharmacy, vol. 38, no. 7, pp. 883–892, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. V. Borhade, H. Nair, and D. Hegde, “Design and evaluation of self-microemulsifying drug delivery system (SMEDDS) of tacrolimus,” AAPS PharmSciTech, vol. 9, no. 1, pp. 13–21, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. Y. Wang, J. Sun, T. Zhang, H. Liu, F. He, and Z. He, “Enhanced oral bioavailability of tacrolimus in rats by self- microemulsifying drug delivery systems,” Drug Development and Industrial Pharmacy, vol. 37, no. 10, pp. 1225–1230, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. A. K. Singh, A. Chaurasiya, A. Awasthi et al., “Oral bioavailability enhancement of exemestane from self-microemulsifying drug delivery system (SMEDDS),” AAPS PharmSciTech, vol. 10, no. 3, pp. 906–916, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. E. B. Basalious, N. Shawky, and S. M. Badr-Eldin, “SNEDDS containing bioenhancers for improvement of dissolution and oral absorption of lacidipine. I. Development and optimization,” International Journal of Pharmaceutics, vol. 391, no. 1-2, pp. 203–211, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. Y. S. R. Elnaggar, M. A. El-Massik, and O. Y. Abdallah, “Self-nanoemulsifying drug delivery systems of tamoxifen citrate: design and optimization,” International Journal of Pharmaceutics, vol. 380, no. 1-2, pp. 133–141, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. M. J. Lawrence and G. D. Rees, “Microemulsion-based media as novel drug delivery systems,” Advanced Drug Delivery Reviews, vol. 45, no. 1, pp. 89–121, 2000. View at Publisher · View at Google Scholar · View at Scopus
  44. S.-X. Cui, S.-F. Nie, L. Li, C.-G. Wang, W.-S. Pan, and J.-P. Sun, “Preparation and evaluation of self-microemulsifying drug delivery system containing vinpocetine,” Drug Development and Industrial Pharmacy, vol. 35, no. 5, pp. 603–611, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. L. Hu, H. Wu, F. Niu, C. Yan, X. Yang, and Y. Jia, “Design of fenofibrate microemulsion for improved bioavailability,” International Journal of Pharmaceutics, vol. 420, no. 2, pp. 251–255, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. A. K. Singh, A. Chaurasiya, M. Singh, S. C. Upadhyay, R. Mukherjee, and R. K. Khar, “Exemestane loaded self-microemulsifying drug delivery system (SMEDDS): development and optimization,” AAPS PharmSciTech, vol. 9, no. 2, pp. 628–634, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. H. Zhang, Y. Cui, S. Zhu, F. Feng, and X. Zheng, “Characterization and antimicrobial activity of a pharmaceutical microemulsion,” International Journal of Pharmaceutics, vol. 395, no. 1-2, pp. 154–160, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. P. K. Ghosh, R. J. Majithiya, M. L. Umrethia, and R. S. R. Murthy, “Design and development of microemulsion drug delivery system of acyclovir for improvement of oral bioavailability,” AAPS PharmSciTech, vol. 7, no. 3, pp. E1–E11, 2006. View at Publisher · View at Google Scholar · View at Scopus
  49. P. Balakrishnan, B.-J. Lee, D. H. Oh et al., “Enhanced oral bioavailability of Coenzyme Q10 by self-emulsifying drug delivery systems,” International Journal of Pharmaceutics, vol. 374, no. 1-2, pp. 66–72, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. R. Parveen, S. Baboota, J. Ali, A. Ahuja, S. S. Vasudev, and S. Ahmad, “Oil based nanocarrier for improved oral delivery of silymarin: In vitro & In vivo studies,” International Journal of Pharmaceutics, vol. 413, no. 1-2, pp. 245–253, 2011. View at Publisher · View at Google Scholar · View at Scopus
  51. A. R. Patel and P. R. Vavia, “Preparation and in vivo evaluation of SMEDDS (self-microemulsifying drug delivery system) containing fenofibrate,” The AAPS Journal, vol. 9, no. 3, pp. E344–E352, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. G. Sharma, K. Wilson, C. F. van der Walle, N. Sattar, J. R. Petrie, and M. N. V. R. Kumar, “Microemulsions for oral delivery of insulin: design, development and evaluation in streptozotocin induced diabetic rats,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 76, no. 2, pp. 159–169, 2010. View at Publisher · View at Google Scholar · View at Scopus
  53. V. Bali, M. Ali, and J. Ali, “Nanocarrier for the enhanced bioavailability of a cardiovascular agent: in vitro, pharmacodynamic, pharmacokinetic and stability assessment,” International Journal of Pharmaceutics, vol. 403, no. 1-2, pp. 45–56, 2011. View at Publisher · View at Google Scholar · View at Scopus
  54. E. Atef and A. A. Belmonte, “Formulation and in vitro and in vivo characterization of a phenytoin self-emulsifying drug delivery system (SEDDS),” European Journal of Pharmaceutical Sciences, vol. 35, no. 4, pp. 257–263, 2008. View at Publisher · View at Google Scholar · View at Scopus
  55. P. Boonme, K. Krauel, A. Graf, T. Rades, and V. B. Junyaprasert, “Characterization of microemulsion structures in the pseudoternary phase diagram of isopropyl palmitate/water/Brij 97:1-butanol,” AAPS PharmSciTech, vol. 7, no. 2, p. E45, 2006. View at Google Scholar
  56. F. Karamustafa and N. Ćelebi, “Development of an oral microemulsion formulation of alendronate: Effects of oil & co-surfactant type on phase behaviour,” Journal of Microencapsulation, vol. 25, no. 5, pp. 315–323, 2008. View at Publisher · View at Google Scholar · View at Scopus
  57. L. M. P. de Campos Araújo, J. A. Thomazine, and R. F. V. Lopez, “Development of microemulsions to topically deliver 5-aminolevulinic acid in photodynamic therapy,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 75, no. 1, pp. 48–55, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. P. Li, A. Ghosh, R. F. Wagner, S. Krill, Y. M. Joshi, and A. T. M. Serajuddin, “Effect of combined use of nonionic surfactant on formation of oil-in-water microemulsions,” International Journal of Pharmaceutics, vol. 288, no. 1, pp. 27–34, 2005. View at Publisher · View at Google Scholar · View at Scopus
  59. S. Shafiq, F. Shakeel, S. Talegaonkar, F. J. Ahmad, R. K. Khar, and M. Ali, “Development and bioavailability assessment of ramipril nanoemulsion formulation,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 66, no. 2, pp. 227–243, 2007. View at Publisher · View at Google Scholar · View at Scopus
  60. S. Shafiq-un-Nabi, F. Shakeel, S. Talegaonkar et al., “Formulation development and optimization using nanoemulsion technique: a technical note,” AAPS PharmSciTech, vol. 8, no. 2, pp. E12–E17, 2007. View at Google Scholar
  61. F. Podlogar, M. Gašperlin, M. Tomšič, A. Jamnik, and M. B. Rogač, “Structural characterisation of water-Tween 40/Imwitor 308-isopropyl myristate microemulsions using different experimental methods,” International Journal of Pharmaceutics, vol. 276, no. 1-2, pp. 115–128, 2004. View at Publisher · View at Google Scholar · View at Scopus
  62. M. Gradzielski, “Recent developments in the characterisation of microemulsions,” Current Opinion in Colloid and Interface Science, vol. 13, no. 4, pp. 263–269, 2008. View at Publisher · View at Google Scholar · View at Scopus
  63. C. Goddeeris, B. Goderis, and G. van den Mooter, “Lyotropic, liquid crystalline nanostructures of aqueous dilutions of SMEDDS revealed by small-angle X-ray scattering: impact on solubility and drug release,” European Journal of Pharmaceutical Sciences, vol. 40, no. 2, pp. 110–117, 2010. View at Publisher · View at Google Scholar · View at Scopus
  64. Y. G. Bachhav and V. B. Patravale, “SMEDDS of glyburide: formulation, in vitro evaluation, and stability studies,” AAPS PharmSciTech, vol. 10, no. 2, pp. 482–487, 2009. View at Publisher · View at Google Scholar · View at Scopus
  65. A. A. Kale and V. B. Patravale, “Design and evaluation of self-emulsifying drug delivery systems (SEDDS) of nimodipine,” AAPS PharmSciTech, vol. 9, no. 1, pp. 191–196, 2008. View at Publisher · View at Google Scholar · View at Scopus
  66. X. Li, Q. Yuan, Y. Huang, Y. Zhou, and Y. Liu, “Development of silymarin self-microemulsifying drug delivery system with enhanced oral bioavailability,” AAPS PharmSciTech, vol. 11, no. 2, pp. 672–678, 2010. View at Publisher · View at Google Scholar · View at Scopus
  67. E. Jantratid, N. Janssen, H. Chokshi, K. Tang, and J. B. Dressman, “Designing biorelevant dissolution tests for lipid formulations: case example—lipid suspension of RZ-50,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 69, no. 2, pp. 776–785, 2008. View at Publisher · View at Google Scholar · View at Scopus